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Introduction 
In recent years, drug delivery to colon has gathered a 
lot of attentions both from pharmaceutical industry and 
academia.  Colonic  drug  delivery  is  significantly 
important  not  just  for  the  delivery  of  protein  and 
peptide  drugs  but  also  for  treatment  of  diseases 
associated with colon such as colon cancer, ulcerative 
Colitis and diarrhea. Colon is believed to be suitable 
adsorption  site  especially  for  poorly  absorbed  drugs 
mostly because of its long retention.
1 
Different  colon  targeted  drug  delivery  systems  have 
been  tried  where  pH,  time,  pressure  dependent  and 
microbially  triggered  systems  are  the  primary 
approaches  for  colon  drug  delivery.
2,3  Recent 
researches are mainly based on the combination of two 
or even more colon-target drug delivery methods. This 
methodology  decreases  the  effect  of  physiological 
changes of gastrointestinal tract and thus facilitates the 
prediction  of  drug  releasing  process  in  different 
conditions.  
Apart  from  large  diversity  in  colonic  drug  delivery 
systems,  nanofibers  containing  drugs  have  been  less 
considered  in  colon-target  delivery  systems.  Various 
approaches can be used for preparation of nanofibers. 
Electrospinning is one of the most reliable techniques 
for  nanofiber  formation.  In  this  method  an  electrical 
charge is applied to draw very fine fiber in nanoscale 
from  a  liquid.  These  electrospun  fibers  have  a  high 
surface to volume ratio which makes them promising 
candidate  in  adsorption  of  less-soluble  drugs.
4-6 
Electrospinning  is  mostly  applied  in  tissue 
engineering,
7  implement  materials,  wound  dressing, 
prosthesis
8 and drug delivery.
9 
Different  parameters  significantly  affect  the  process 
namely:  molecular  weight,  solution  characteristics 
(viscosity,  surface  tension  and  conductivity),  electric 
potential, concentration, distance between the capillary 
and  collector  screen,  temperature,  humidity  and  air 
velocity in the chamber.
10 
A lot of researches have revealed that indomethacin can 
be  effective  in  colon  cancer  treatment.  However, 
indomethacin as a non-steroidal anti-inflammatory drug 
(NSAIDS)  has  a  lot  of  adverse  effects  on 
gastrointestinal tract. Therefore this drug was chosen in 
colon-targeted  drug  delivery  process.  On  the  other 
hand, indomethacin is a less soluble drug which makes 
that a promising candidate for electrospunnanofibers.  
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Purpose: The objective of this study was to prepare a suitable form of nanofiber for 
indomethacin using polymers Eudragit RS100 (ERS) and Eudragit S100 (ES) and to 
evaluate  the  effect  of  some  variables  on  the  characteristics  of  resulted 
electrospunnanofibers. Methods: Electrospinning process was used for preparation of 
nanofibers. Different solutions of combinations of ERS, ES and indomethacin in various 
solvents and different ratios were prepared. The spinning solutions were loaded in 10 
mL syringes. The feeding rate was fixed by a syringe pump at 2.0 mL/h and a high 
voltage  supply  at  range  10-18  kV  was  applied  for  electrospinning. 
Electrospunnanofibers were collected and evaluated by scanning electron microscopy, 
differential scanning calorimetry and FTIR for possible interaction between materials 
used  in  nanofibers.  The  effect  of  solvent  and  viscosity  on  the  characteristics  of 
nanofibers  also  was  investigated.  Results:  Fiber  formation  was  successful  using  a 
solvent ethanol and mixture of ERS and ES. Increase in viscosity of ethanolic solutions 
of ERS followed by addition of ES in the solution led to preparation of smooth fibers 
with larger diameters and less amounts of beads. DSC analysis of fibers certified that 
indomethacin  is  evenly  distributed  in  the  nanofibers  in  an  amorphous  state.  FTIR 
analysis did not indicate significant interaction between drug and polymer. Conclusion: 
It  was  shown  that  drug-loaded  ERS  and  ES  nanofibers  could  be  prepared  by  exact 
selection of range of variables such as type of solvent, drug: polymer ratio and solution 
viscosity and the optimized formulations could be useful for colonic drug delivery. 
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The objective of this study was to evaluate the effect of 
two  factors  (ratio  of  Eudragit  S100:  Eudragit  RS100 
and  ratio  of  drug:  polymer)  on  morphological 
characteristics  of  indomethacin  nanofibers  and 
optimize  formulation  variables  such  as  viscosity  of 
electropinning solutions and type of solvents in order to 
obtain  the  best  colonic  drug  delivery  system  for 
indomethacin. 
 
Materials and Methods 
Materials 
Indomethacin  (Darupakhsh  Pharmaceutical 
manufacturing company, Tehran, Iran), Eudragit  S100 
(ES)  and  Eudragit  RS100  (ERS)  (Rohm  Pharma, 
GmbH, Germany), sodium chloride and potassium di-
hydrogen phosphate (Merck, Germany) were obtained 
from the indicated sources. 
 
Preparation of Electrospinning Solutions  
25%  (w/v)  solution  of  Eudragit  RS  and  15%  (w/v) 
dispersion  of  drug  were  prepared  in  water.  Then 
electrospining solution with proportion of 1:1(v/v) for 
drug  and  polymer  was  made.  The  same  work  was 
carried out by ethanol as the solvent. On the other hand, 
25%  (w/v)  solutions  of  polymethacrylates  (ERS  and 
ES) and 15% (w/v) solution of drug were prepared in 
ethanol as a good solvent. The ratios of ES: ERS were 
30:70, 50:50 and 70:30.  Then electrospining solution 
with ratio of 1:1(v/v) for drug and polymers was made. 
Further  formulations  with  The  ratios  of  20:80,  80:20 
and 100:0 for ES: ERS and the electrospining solution 
with  ratios of drug: polymer at range 1:1,1.5:1, 2:1, 
and  2.5:1(v/v)  were  also  prepared.  Finally,  regarding 
the  characteristics  and  reproducibility  of  preliminary 
formulations the least and most levels were considered 
to design a series of runs according to a 3
2 full factorial 
design. The ratio of drug to polymer and ES: ERS was 
considered  as  the  independent  variables.  Table  1 
summarizes  the  independent  variables.  The  resulted 
formulations of factorial design are listed in Table 2. 
 
      Table 1. Experimental design: factors and responses 
Independent variables  -1  0  +1 
X1: Ratio of Eudragit S100: RS100  20:80  60:40  100:0 
X2: Drug:polymer ratio  1:1  1.5:1  2:1 
 
Electrospinning Process 
The spinning solutions were loaded in 10 mL syringes. 
The  feeding  rate  was  controlled  by  a  syringe  pump 
(Cole-Pham®, USA) and was fixed at 2.0 mL/h. A high 
voltage supply fixed at 10-18 kV was applied, and a 
piece of aluminum foil was used to collect the ultrafine 
fibers  with  a  horizontal  distance  of  15  cm  from  the 
needle  tip.  Electrospunnanofibers  were  collected  and 
stored in desiccator for more studies. 
 
Table 2. Composition of experimental formulations (runs) 
Formulation  X1  X2 
F1  -1  -1 
F2  -1  0 
F3  -1  +1 
F4  0  -1 
F5  0  0 
F6  0  +1 
F7  +1  -1 
F8  +1  0 
F9  +1  +1 
 
Scanning Electron Microscopy 
The  surface  morphologies  of  electrospun  fibers  were 
assessed  using  a  LEO  -  rp-1455  scanning  electron 
microscope  (SEM).  Prior  to  the  examination,  the 
samples  were  silver  sputter-coated  under  argon  to 
render them electrically conductive. The pictures were 
then taken at an excitation voltage of 15 kV.  
 
Differential Scanning Calorimetry 
DSC analyses were carried out using a Mettler-Ms603s 
differential scanning calorimeter. Sealed samples were 
heated at 30 ºC/min from 20 to 280 ºC.  
 
Fourier Transformed Infrared Spectroscopy 
FTIR was conducted using a Nicolet-Nexus 670 FTIR 
spectrometer.  The  samples  were  prepared  using  the 
KBr disk method (2 mg sample in 200 mg KBr) and the 
scanning range was 500–4000 cm
−1 with a resolution of 
2 cm
−1. 
 
Results and Discussion 
Preparations of Drug-Loaded Nanofibers 
Suitable  selection  of  solvent  is  one  of  the  most 
important  factors  for  successful  preparation  of 
electrospun polymer nanofibers.
11-13 The solvent should 
be  able  to  dissolve  the  drug  easily  as  well  as 
maintaining  electrospinnability  of  polymer  solutions. 
Eudragit RS100 could be electrospun into fibers when 
methanol or ethanol was used as the solvent.
14 In our 
study, ERS aqueous solutions were unspinnable. Only 
discrete  droplets  were  observed  when  they  were 
subjected to the electrospinning process. 
Nanofibers from ERS in ethanol showed discrete beads 
and/or beaded fibers when the viscosity of the solution 
was  low.  The  formation  of  half-hollowed  beads  was 
thought to be a result of the evaporation of the solvent 
from the beads. Further increase in solution viscosity 
by addition of ES resulted in the formation of smooth 
fibers with larger diameters (Figure 1).  
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Figure 1. SEM images of formulations with ES: ERS in the 
ratios of ; (a) 30:70, (b) 50:50 and (c) 70:30 (magnification ×1000). 
 
SEM images of drug loaded nanofibers with different 
amounts  of  indomethacin  and  various  ratios  of  ES: 
ERS asserted that nanofiber formation is just possible 
with ratios of drug: polymer in ranges 1:1, 1.5:1 and 
2:1 and ratio of 2.5:1 did not form suitable nanofiber in 
all  ratios  of  polymers.  Also,  nanofiber  formation  in 
formulations with drug: polymer ratios of 2:1 and 1.5:1 
was only occurred when the ratio of ES: ERS was in 
range  20:80  and  100:0.  This  result  could  be  to  the 
decrease  in  viscosity  of  electrospinning  solutions 
affected  by  increase  in  amount  of  drug  which  in 
consequence  disrupted  nanofiber  formation  process. 
SEM images of drug loaded nanonfibers are presented 
in Figure 2. Solution viscosity plays an important role 
in  determining  the  fiber  size  and  morphology  during 
spinning  of  polymeric  fibers.  When  the  solution 
viscosity decreases surface tension has the overcoming 
influence on fiber morphology with the final results of 
decrease  in  fiber  diameters  and  bead  formation. 
Correlation  between  the  polymer  viscosity  and/or 
concentration  and  fibers  formed  from  electrospinning 
has  been  surveyed  in  a  number  of  studies.
15-19 
Chowdhury  et  al.  investigated  the  effect  of 
experimental  parameters  such  as  polymer 
concentration,  viscosity  and  surface  tension  on  the 
morphology of electrospun Nylon 6 fibers. They found 
that  increase  in  the  concentration  and  viscosity  and 
lowering surface tension manages to formation of the 
uniform nanofibers.
20 
Finally,  according  to  preformulation  studies  ratios  of 
1:1, 1.5:1 and 2:1 for drug: polymer and 20:80, 60:40 
and  100:0  for  ES:  ERS  were  selected  to  design  9 
formulations  based  on  full  factorial  design.  Figure  3 
shows  SEM  images  of  formulations  containing  ES: 
ERS at the ratio 60:40 ES: ERS and drug: polymer at 
ranges  1:1,  1.5:1  and  2:1.Comparing  SEM  Figures  2 
and 3 it can be seen that addition of ES could lead to 
the  formation  of  smooth  fibers  with  larger  diameters 
and low beads which could be illustrated by increase in 
viscosity of electrospinning solutions. 
 
Physical State of Components in the Nanofibers 
DSC thermograms of drug and Eudragits are shown in 
Figure  4.  The  DSC  curve  of  pure  indomethacin 
indicated a single endothermic response corresponding 
to a melting point of 179 ºC (Figure 4a). The composed 
of pure ERS exhibited a single endothermic response in 
115 ºC, suggesting that Eudragit RS is in amorphous 
state  (Figure  4b).  On  the  other  hand,  ES  showed  a 
single  endothermic  response  in  142  ºC  (Figure  4c). 
Figure  5  illustrates  thermograms  of  formulations 
resulted from factorial design. According to Figure 5, 
all formulations exhibited a broadband wide endotherm 
ranging  from  190  to  240  ◦C  which  could  be  due  to 
polymer  melting.  In  addition,  melting  point  peak  of 
indomethacin  was  removed  in  all  formulation  and  it 
may  be  caused  by  the  presence  of  Eudragits  that 
resulted  in  a  loss  of  crystalline  content  of 
indomethacin. The presence of an endothermic peak at 
60°C in some formulations (F1, F3, F4 and F5) could 
be due to lowering of Tg of Eudragits by addition of 
drug to the formulation composition. This phenomenon 
was more obvious in formulations containing Eudragit 
RS.  Plasticizing  effect  of  NSAIDs  and  increase  in 
macromolecular mobilities of polymeric chains due to 
presence  of  these  drugs  has  been  previously 
demonstrated.
21,22  DSC  studies  demonstrated  that 
distribution of drug molecules in the nanonfiber structure 
was  occurred  with  change  in  state  of  drug  from 
crystallinity to amorph status.  
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Figure 2. SEM images of formulations; range of ES:ERS and drug:polymer was (a)  20:80 and 1:1, (b) 20:80 and 1.5:1, (c) 20:80 and 
2:1, (d) 80:20 and 1:1, (e) 100:0 and 1:1, (f) 100:0 and 1.5:1. 
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Figure 3. SEM images of formulations with ES:ERS in the ratio 
of 60:40 and different ratios of drug: polymer; (a) 1:1 ratio, (b) 
1.5:1 ratio, and (c) 2:1 ratio. 
 
Compatibility of Nanofiber Components 
FTIR  spectra  of  drug,  polymers  and  formulation  F1 
was shown in Figure 6. Accordingly, the spectrum of 
indomethacin showed bands characteristic of secondary 
carbonyl groups (C=O) at 1714 cm
−1, (C=O amid) in 
1690  cm
-1,  phenyl  groups  (C=C  stretch  vibration)  at 
1523 cm
−1 and (O-H stretch vibration) at 3022 cm
−1. 
The spectrum of ERS had a broad band characteristic 
of  groups  carbonyl  (C=O)  at  1723  cm
−1,  and  ester 
linkages  (C-O  stretch  vibration)  at  1149  cm
−1.  The 
spectrum of ES showed a broad band characteristic of 
carbonyl  groups  (C=O)  at  1727  cm
−1,  characteristic 
bands  of  hydroxyl  groups  (C-H  stretch  vibration)  at 
2957 cm
−1. Two other spectra at 1152 and 3087 cm
-1 
were also indicative of C-O and O-H stretch vibration, 
respectively.  FTIR  of  formulation  F1  exhibited  the 
same  spectra  which  in  result  there  would  be  no 
significant  shift  in  spectra  and  interactions  between 
drug  and  polymer  was  not  seen.  Interaction  between 
ionizable drugs and eudragits was investigated in some 
researchs.  For  example  Heun  et  al.  foundinteractions 
between drugs and Eudragits RL/RS resins in aqueous 
environment.
23 Also in the other study ionic interaction 
between propranolol hydrochloride and three different 
anionic polymers Eudragit  S 100,  Eudragit L  100-55 
and  sodium  carboxymethylcellulose  was 
demonstrated.
24 However,  in  our  study  there  was  no 
any significant ionic or hydrogenic interaction between 
drug and polymers. 
 
 
Figure 4. DSC thermograms of (a) drug, (b) Eudragit RS100 
and (c) Eudragit S100. 
 
 
 
Figure  5.  DSC  thermograms  of  formulations  resulted  from 
factorial design 
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Figure 6. FTIR spectra of (a) indomethacin, (b) Eudragit RS, 
(c) Eudragit S, and (d) formulation F1 
 
Conclusion 
Combination  of  Eudragit  RS  and  Eudragit  S  for 
prepration of nanofibers containing indomethacin using 
electrospinning  method  was  successfully  tried. 
Accurate selection of solvent, viscosity, and ratios of 
ERS:  ES  and  drug:  polymer  was  important  for 
successful preparation of electrospunnanofibers. In the 
entire  composite  nanofibers  drug  was  present  in  an 
amorphous  state.  The  optimized  formulations  were 
capable of drug loading up to 66% and could be useful 
for  further  studies  on  possible  colonic  delivery  of 
indomethacin. 
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